BioWorld

Feb. 9, 2001

View Archived Issues

Other News To Note

Read More

Structural GenomiX, Foundation Enter $13M Deal Around CFTR

Read More

Cell Pathways Files Shelf Statement For Up To $25M

Read More

Corrections

Read More

QLT Shows Visudyne Benefits Occult CNV; Stock Rises 35%

Read More

Mayxgen Enters $80M Deal With Dutch Allergy Specialist

Read More

Hybrigenics, Servier Collaborate On Proteomics Against Cancer

Read More

Chirac Decries Cloning, Calls For More Research In Adult Stem Cells

Read More